Should we? These experts answer that question in Part 2 of our Talking Techniques podcast with BioTechniques: David Dimmock Senior Medical Director at Rady Children’s Institute of Genomic Medicine Christine Stanley Chief Director of Clinical Genomics at Variantyx Take Ogawa Chief Commercial Officer at Psomagen RELATED CONTENT: 🎥 VIDEO Whole-Genome Sequencing for Precision Medicine […]
Join us as we talk with experts in rare disease research, clinical practice, and WGS technology about how its bringing disease diagnostics and treatment to life: David Dimmock Senior Medical Director at Rady Children’s Institute of Genomic Medicine Alan Beggs Director of The Manton Center for Orphan Disease Research at Boston Children’s Hospital Sir Edwin […]
This video explores how clinical whole genome sequencing (WGS) is bringing precision medicine to life with new treatments, advanced diagnostics, and more. Join us as we introduce the technique’s impact from academic research to clinical application. RELATED CONTENT: 🎙 PODCAST Talking Techniques: Episode 1 Whole-Genome Sequencing: Navigating the ‘Diagnostic Odyssey’ in Rare Disease Research […]
RELATED CONTENT: 🎥 VIDEO Whole-Genome Sequencing for Precision Medicine 🎙 PODCAST Talking Techniques: Episode 1 Whole-Genome Sequencing: Navigating the ‘Diagnostic Odyssey’ in rare disease research 🎙 PODCAST Talking Techniques: Episode 2 The Ethics of Whole-Genome Sequencing: From Race and Religion to Science Fiction 📊 INFOGRAPHIC WGS vs WES vs Genotyping for Precision Medicine
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.